22.06.20 ijBio Portfolio
Infojet ClubPharm Involved.
$1,000,000 on 12.06.20 Changes for 22.06.20:
AstraZeneca (AZN) $51,3 $53,4 (+4%) $104,000
Inovio (INO) $13,2 $15,3 (+15.9%) $115,900
Moderna (MRNA) $61,5 $64,7 (+5.2%) $105,200
Abbot (ABT) $88,5 $90,3 (+2%) $102,000
Gilead (GILD) $72,5 $75,7 (+4.4%) $104,400
Adaptive (ADPT) $42,2 $46 (+9%) $109,000
CytoDyn (CYDY) $3,12 $4,2 (+34.6%) $134,600
AbbVie (ABBV) $92,2 $97,3 (+5.5%) $105,500
Arcus (RCUS) $27,3 $25,8 (-5.5%) $94,500
Sorrento (SRNE) $4,6 $4,9 (+6.5%) $106,500
At close 22.06.20= $1,081,600 ( +4,85%)
per million dollars at 10% per share.
At close 19.06.20= $1,031,500 (+3,15%)
during the week 12-19.06 +3%
12.06.20 = $1,000,000
Global Communication Platforms portfoilio
--
Portfolio News:
Sanofi, Translate Bio in Vaccine Pact for Covid-19, Flu
Sanofi and Translate Bio to expand vaccine collaboration
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
TickmillАкция кэшбеков в Tickmill™
Edited Transcript of LIFE earnings conference call or presentation 12-May-20 9:00pm
Gilead Analyst Questions Remdesivir's Ultimate Upside As Study Begins For Inhaled Version
Coronavirus Latest: Monday, June 22
NYU Pulmonologist: COVID-19 is ‘a virus not like any other we’ve seen’
Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End
© 2020 Verizon Media. All rights reserved.
Data DisclaimerHelpSuggestions
Privacy (Updated)About Our AdsTerms (Updated)Sitemap